MONTCLAIR, NJ - The Cancer Center at Mountainside Medical Center recently successfully completed its first use of Netspot, a radiological breakthrough that enhances PET scan images and facilitates more precise diagnosis and treatment of neuroendocrine tumors (NETs).
“The use of Netspot in conjunction with the hospital’s state-of-the-art PET scan technology underscores our ability to provide patients with convenient access to the most current, effective diagnostic and treatment options close to home,” said Dr. John Conti, Medical Director of the Cancer Center at Hackensack Meridian Health Mountainside Medical Center. “Utilizing the extensive resources we have available on-site and within our network, our multidisciplinary team of specialists offers a standard of cancer care that is unsurpassed.”
About NETs and Netspot
NETs, which can be benign or cancerous, originate in hormone-producing neuroendocrine cells. They can occur throughout the body but are most often found in the lungs, appendix, small intestine, rectum and pancreas. Although the incidence of NETs is rare, they are often asymptomatic and can go undetected until they are advanced.
Positron emission tomography (PET) scans are typically used to diagnose and manage the treatment of NETs. Netspot, the first FDA approved product for the preparation of an injection of gallium Ga 68 dotatate, a radioactive agent that binds to somatostatin receptors (SSTRs), is administered prior to the PET scan. It facilitates greater acuity and better detection and assessment of NETs because SSTRs are characteristically present in excess at the site of a neuroendocrine tumor.
“Netspot is just one of many recent breakthroughs in the early detection and successful treatment of various forms of cancer,” observed Dr. Conti, a board-certified medical oncologist. “At Mountainside Medical Center, we keep abreast of such developments to ensure that our patients can receive these emerging alternatives in the comfort of our community hospital.”
About Hackensack Meridian Health Mountainside Medical Center
Mountainside Medical Center has been serving Montclair and its surrounding New Jersey communities since 1891. The hospital provides patients immediate access to innovative and effective treatment alternatives at specialized centers within the hospital that focus on imaging, women’s health, cancer care, surgery, obesity, stroke and chronic kidney disease. Mountainside Medical Center is designated as a Primary Stroke Center by the NJ State Department of Health and Senior Services and is one of only a few community hospitals licensed by the State to perform emergency cardiac angioplasty. To learn more about Mountainside Medical Center visit www.mountainsidehosp.com.